Keith B. Glaser

Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines.

Keith B. Glaser, Michael J. Staver, Jeffrey F. Waring et al. · PubMed · 2003 · 524 citations

Histone Modifications, Hdac Inhibitors, Epigenetic Change +22

HDAC inhibitors: Clinical update and mechanism-based potential

Keith B. Glaser · Biochemical Pharmacology · 2007 · 347 citations

Medicinal Chemistry, Hdac Inhibitors, Medicine +6

Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA

Keith B. Glaser, Junling Li, Michael J. Staver et al. · Biochemical and Biophysical Research Communications · 2003 · 218 citations

Histone Modifications, Tumor Biology, Chromatin +11

Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.

John C. Mathison, G. Duke Virca, Eliza B. Wolfson et al. · Journal of Clinical Investigation · 1990 · 205 citations · Full text

Discovery of<i>N</i>-(4-(3-Amino-1<i>H</i>-indazol-4-yl)phenyl)-<i>N</i>‘-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor

Yujia Dai, Kresna Hartandi, Zhiqin Ji et al. · Journal of Medicinal Chemistry · 2007 · 180 citations · Full text

Compound 17P, Drug Target, Chemoprevention Strategy +20